Circular Issued By The Minister Of Public Health On Hospitalization

التصنيف العلاجي	الاسم	أساسي / جنيسي	التركيبة العلمية	العيار	الشكل الصيدلاني	سعر المبيع من العموم
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 100mg	100mg	Capsule, hard	4,511,279 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 100mg	100mg	Capsule, hard	5,590,385 L.L
L01AX03	TEGOZOL	G	Temozolomide - 100mg	100mg	Capsule	5,012,533 L.L
L01AX03	TEMODAL	B	Temozolomide - 100mg	100mg	Capsule	7,731,224 L.L
L01AX03	TEMOZOLOMIDE GP PHARM	G	Temozolomide - 250mg	250mg	Capsule, hard	12,058,004 L.L
L01AX03	TEMOZOLOMIDE ACCORD	G	Temozolomide - 250mg	250mg	Capsule, hard	13,397,927 L.L
L01AX03	TEGOZOL	G	Temozolomide - 250mg	250mg	Capsule	24,856,894 L.L
L01AX03	TEMODAL	B	Temozolomide - 250mg	250mg	Capsule	18,516,505 L.L
L01AC01	TEPADINA	G	Thiotepa - 100mg	100mg	Injectable powder for concentrate for solution	98,197,306 L.L
L01AA09	BENDAVIVAL	G	Bendamustine HCl - 100mg	100mg	Injectable concentrated powder for solution	26,072,618 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (100mg)	2.5mg/ml	Injectable powder for concentrate for solution	16,887,989 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE GP PHARM	G	Bendamustine HCl - 100mg/50ml	100mg/50ml	Injectable powder for concentrate for solution	78,439,178 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 100mg/50ml	100mg/50ml	Injectable powder for concentrate for solution	78,439,178 L.L
L01AA09	RIBOMUSTIN	B	Bendamustine HCl - 100mg	100mg	Injectable powder for concentrate for solution	31,939,807 L.L
L01AA09	RIBOMUSTIN	B	Bendamustine HCl - 100mg	100mg	Injectable powder for concentrate for solution	31,939,807 L.L
L01AA09	BENDAMUSTINE MEDAC	G	Bendamustine HCl - 2.5mg/ml (25mg)	2.5mg/ml	Injectable powder for concentrate for solution	24,934,922 L.L
L01AA09	BENDAMUSTINE HYDROCHLORIDE	G	Bendamustine HCl - 25mg/10ml	25mg/10ml	Injectable powder for concentrate for solution	19,610,153 L.L
L01AA06	HOLOXAN	B	Ifosfamide - 1g	1g	Injectable powder for solution	3,586,850 L.L
L01AA01	ENDOXAN	B	Cyclophosphamide (monohydrate) - 500mg	500mg	Injectable powder for solution	764,646 L.L
J07CA11	DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE	B	Diphteria Toxoid1 - ?25Lf (?30IU)/0.5ml, Tetanus toxoid1 - ?2.5Lf (?40IU)/0.5ml, Bordetella pertussis (Whole cell) - ?16OU (?4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ?10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ?1.25mg , 2 conjugated to tetanos toxoid carrier protein -		Injectable suspension	1,515,854 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg		Injectable suspension	4,462,901 L.L
J07CA09	INFANRIX HEXA	B	Diphteria toxoid purified (Prefilled syringe) - ?30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ?40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml		Injectable suspension	4,230,416 L.L
J07CA06	PENTAXIM	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	2,558,676 L.L
J07CA06	INFANRIX IPV + HIB	B	Poliomyelitis virus type 3 inactivated(Prefilled syringe) - 32D.U., Poliomyelitis virus type 2 inactivated(Prefilled syringe) - 8D.U., Poliomyelitis virus type 1 inactivated(Prefilled syringe) - 40D.U., Bordetella pertussis antigen(Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg, Tetanus toxoid (Prefilled syringe) - ?40IU, Diphtheria toxoid (Prefilled syringe) - ?30IU, H. Influenza type b polysaccharide(Vial) - 10mcg		Injectable dry powder+suspension	3,014,239 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactivé adsorbé)	B	Diphteria toxoid purified - ?30IU, Tetanus toxoid purified - ?40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg		Injectable suspension	1,628,737 L.L
J07CA	LANTIGEN B	B	Streptococcus pneumoniae type 3 (antigenic extracts) - 63.2A.U./ml, Streptococcus pyogenes group A (antigenic extracts) - 126.2A.U./ml, Branhamella catarrhalis (antigenic extracts) - 39.9A.U./ml, Staphylococcus aureus (antigenic extracts) - 79.6A.U./ml, Haemophilus influenzae type b (antigenic extracts) - 50.2A.U./ml, Klebsiella pneumoniae (antigenic extracts) - 39.8A.U./ml		Drops suspension	916,501 L.L
J07BX05	ABRYSVO	B	RSV subgroup A stabilized perfusion F antigen 60mcg - 60mcg, RSV subgroup B stabilized perfusion F antigen 60mcg - 60mcg, Glycoprotein F stabilized in the perfusion conformation -		Injectable powder + solvent	22,650,721 L.L
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml		Injectable suspension	14,139,396 L.L
J07BK01	VARICELLA VACCINE LIVE	BioTech	Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated -		Injectable suspension	3,104,276 L.L
J07BK01	VARIVAX	B	Varicella virus, live attenuated - 1350PFU		Injectable powder for suspension+diluent	4,102,751 L.L